Skip to main content
logo
TELA Bio, Inc. (TELA)
NASDAQ: TELA · Real-Time Price · USD
0.8039
+0.0229 (2.93%)
Sep 4, 2026, 12:04 PM EDT - Market open

TELA Bio Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
79.9180.2869.358.4541.4229.46
Revenue Growth
6.09%15.84%18.56%41.13%40.58%61.77%
Gross Profit
54.5754.7246.8740.4927.8519.12
Operating Income
-34.01-33.76-41.7-44.08-39.01-29.45
Net Income
-41.18-38.83-37.84-46.66-44.3-33.28
Earnings Per Share
-0.78-0.83-1.33-2.04-2.72-2.30
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
30.4250.8552.6746.7342.0243.93
Total Debt
57.9257.6541.6742.7740.2631.49
Net Cash (Debt)
-27.49-6.81113.961.7612.44
Net Cash Growth
--177.52%124.84%-85.83%-71.45%
Net Cash Per Share
-0.52-0.150.390.170.110.86

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-31.14-28.22-41.6-40.86-40.75-30.43
Capital Expenditures
-0.48-0.45-0.99-0.61-0.87-0.63
Free Cash Flow
-31.62-28.67-42.58-41.47-41.62-31.06
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
68.29%68.17%67.63%69.27%67.24%64.89%
Operating Margin
-42.56%-42.05%-60.17%-75.40%-94.18%-99.96%
Pretax Margin
-51.20%-48.09%-54.81%-79.83%-106.95%-112.94%
Profit Margin
-51.53%-48.37%-54.61%-79.83%-106.95%-112.94%
FCF Margin
-39.57%-35.71%-61.45%-70.94%-100.49%-105.42%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
0.470.661.722.775.326.30